Key facts
- This page summarizes Susan E. Burwig's Form 4 filing for Medpace Holdings, Inc. (MEDP).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 17 Sep 2026, 16:35.
Susan E. Burwig - 15 Sep 2026 Form 4 Insider Report for Medpace Holdings, Inc. (MEDP)
- Reporting relationship
- Exec. VP, Operations
- Issuer ticker
- MEDP
- Reported as of
- 15 Sep 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 17 Sep 2026, 16:35:29 UTC
- Prior SEC filing
- 29 Jul 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Stephen P. Ewald, Attorney-in-Fact for Susan E. Burwig
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Susan E. Burwig filed Form 4 for Medpace Holdings, Inc. (MEDP) on 17 Sep 2026.
Change
- Previous filing in this sequence was filed on 29 Jul 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001677418
Primary reporting owner
BURWIG SUSAN E
- Relationship
- Exec. VP, Operations
- Address
- C/O MEDPACE HOLDINGS, INC., 5375 MEDPACE WAY, CINCINNATI
- Signature
- /s/ Stephen P. Ewald, Attorney-in-Fact for Susan E. Burwig
- Signature date
- 17 Sep 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MEDP
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +3,000
- Change %
- +4.8%
- Price
- $166.73*
- Shares after
- 65,984
- Date
- 15 Sep 2026
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MEDP
transaction
Derivative
Employee Stock Option (Right to Buy)
Options Exercise
- Transaction value
- Shares
- -3,000
- Change %
- -27%
- Price
- $0.000000*
- Shares after
- 8,028
- Date
- 15 Sep 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,000
- Exercise price
- $166.73
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The option vested in full on October 27, 2025.